Bayer Sheds Woman’s Suit Linking MRI Contrast Dye to Injury

Bayer Healthcare Pharmaceuticals Inc. got an early exit from a woman’s suit alleging she suffered permanent harm caused by its Magnevist contrast dye.

Lori Combs’s suit was barred by Ohio’s two-year time limit, the U.S. District Court for the Northern District of Ohio ruled May 15.

Combs received Magnevist, a gadolinium-based medical contrast agent used to enhance MRI images, in 2006.

She allegedly suffered gadolinium retention in multiple organs and soft tissues, causing damage to her kidneys, muscles, and bone.

Ohio’s statute of limitations starts to run when a plaintiff is informed by a medical professional that the injury is ...